Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2005

View Archived Issues

RG-108 reactivates tumor suppressor genes by reverting epigenetic mutations in cancer cells

In vitro antiangiogenic actions of pasireotide compared to octreotide

Transferrin receptor revealed as a novel cancer target

New data on the antitumor effects and safety of ZD-6474 in solid malignancies

Response to HSPPC-96 is not affected by cytokines in advanced melanoma patients

ADAM33 gene involved in embryonic airway development and determines severity of COPD

QR-333 safely reduces symptoms of diabetic peripheral neuropathy

Pegvisomant treatment benefits patients with acromegaly

Bosentan shows efficacy in stabilizing disease in patients with advanced melanoma

New phase II data supports the use of Rambazole in acne

Snapshots on pregabalin in epilepsy and neuropathic pain

Novagali Pharma completes initial clinical evaluation of proprietary oral paclitaxel

Novartis reports promising phase III data with SPP-100 for hypertension

Cytheris initiates additional phase I/II trial with recombinant interleukin-7

FDA grants full approval to Arimidex for treatment of postmenopausal breast cancer

The Immune Response Corporation reports update on HIV and MS clinical programs

Curis and Procter & Gamble collaborate on hair growth program

NeuTec Pharma to evaluate Mycograb for breast cancer

Tachykinin antagonists prepared and tested at Takeda

Celera begins phase I clinical evaluation of cathepsin S inhibitor for psoriasis

Celtic Pharma acquires worldwide rights to Xerecept

Isis begins phase II development of second-generation antisense drug for high cholesterol

Medicure receives FDA fast track designation for MC-1

Novel antidiabetic agents disclosed in recent patent literature

Pfizer receives nonapprovable letter in U.S. for COX-2 inhibitor for acute pain

UCB's antiepileptic Keppra approved in E.U.

Novartis reports phase III data and update of R&D pipeline

Anti-HEH4 antibodies claimed for bone or cartilage-related disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...